Cover Story
Publication date: December 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 12Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 15, 2020 Category: Cancer & Oncology Source Type: research
Targeting human MutT homolog 1 (MTH1) for cancer eradication: current progress and perspectives
Publication date: December 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 12Author(s): Yizhen Yin, Fener Chen (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 15, 2020 Category: Cancer & Oncology Source Type: research
The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
Publication date: Available online 14 December 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Zhenzhen Li, Zhen Guo, Rui Lan, Sidong Cai, Zhirong Lin, Jingyan Li, Junjian Wang, Zhuoming Li, Peiqing Liu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 15, 2020 Category: Cancer & Oncology Source Type: research
3D organoids derived from the small intestine: An emerging tool for drug transport research
Publication date: Available online 13 December 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Yuanjin Zhang, Shengbo Huang, Weiguo Zhong, Wenxia Chen, Bingyi Yao, Xin Wang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 15, 2020 Category: Cancer & Oncology Source Type: research
An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation
Publication date: Available online 13 December 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Mirja Harms, Monica M.W. Habib, Simona Nemska, Antonella Nicolò, Andrea Gilg, Nico Preising, Pandian Sokkar, Sara Carmignani, Martina Raasholm, Gilbert Weidinger, Gönül Kizilsavas, Manfred Wagner, Ludger Ständker, Ashraf H. Abadi, Hassan Jumaa, Frank Kirchhoff, Nelly Frossard, Elsa Sanchez-Garcia, Jan Münch (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 15, 2020 Category: Cancer & Oncology Source Type: research
The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?
Publication date: Available online 9 December 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Yani Liu, Zongtao Liu, Kewei Wang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 9, 2020 Category: Cancer & Oncology Source Type: research
Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency
Publication date: Available online 5 December 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Xinyu Lou, Dong Zhang, Hao Ling, Zhonggui He, Jin Sun, Mengchi Sun, Dongchun Liu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 6, 2020 Category: Cancer & Oncology Source Type: research
Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer
Publication date: Available online 2 December 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Shipeng He, Junhui Ma, Yuxin Fang, Ying Liu, Shanchao Wu, Guoqiang Dong, Wei Wang, Chunquan Sheng (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 3, 2020 Category: Cancer & Oncology Source Type: research
Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding
Publication date: November 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 11Author(s): Yang Song, Xiangfu Guo, Jijun Fu, Bing He, Xueqing Wang, Wenbing Dai, Hua Zhang, Qiang Zhang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 1, 2020 Category: Cancer & Oncology Source Type: research
Tailored core‒shell dual metal–organic frameworks as a versatile nanomotor for effective synergistic antitumor therapy
Publication date: November 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 11Author(s): Biyuan Wu, Jintao Fu, Yixian Zhou, Sulan Luo, Yiting Zhao, Guilan Quan, Xin Pan, Chuanbin Wu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 1, 2020 Category: Cancer & Oncology Source Type: research
Table of Contents
Publication date: November 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 11Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 1, 2020 Category: Cancer & Oncology Source Type: research
Cover Story
Publication date: November 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 11Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 1, 2020 Category: Cancer & Oncology Source Type: research
Editor Profiles: Guest Editors of Special Issue “Tumor Microenvironment and Drug Delivery”
Publication date: November 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 11Author(s): (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 1, 2020 Category: Cancer & Oncology Source Type: research
Editorial of Special Issue on Tumor Microenvironment and Drug Delivery
Publication date: November 2020Source: Acta Pharmaceutica Sinica B, Volume 10, Issue 11Author(s): Huile Gao, Zhiqing Pang, Wei He (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - December 1, 2020 Category: Cancer & Oncology Source Type: research
Constitutive androstane receptor induced-hepatomegaly is partially via yes-associated protein activation
Publication date: Available online 28 November 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Yue Gao, Shicheng Fan, Hua Li, Yiming Jiang, Xinpeng Yao, Shuguang Zhu, Xiao Yang, Ruimin Wang, Jianing Tian, Frank J. Gonzalez, Min Huang, Huichang Bi (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - November 29, 2020 Category: Cancer & Oncology Source Type: research
